Sanjuan-Cerveró Rafael, Carrera-Hueso Francisco J, Vazquez-Ferreiro Pedro, Fikri-Benbrahim Narjis, Franco-Ferrando Nuria, Peimer Clayton A
Orthopedics and Traumatology Service, Hospital de Denia, Dénia, Alicante, Spain; University of Granada, Granada, Spain.
Pharmacy Service, Hospital Dr Moliner, Porta Coeli s/n Serra, Valencia, Spain.
J Hand Surg Am. 2017 Feb;42(2):e109-e114. doi: 10.1016/j.jhsa.2016.11.032.
The primary objective of this study was to quantify the degree of pain associated with collagenase Clostridium histolyticum (CCH) injection and to determine whether it is related to other factors in the intervention.
A prospective study of 135 patients was performed to evaluate pain at 3 points during treatment: (1) after CCH injection, using a numerical rating scale (NRS), (2) a binary (positive/negative) assessment before manipulation 24 hours after CCH and after removing the bandage, and (3) after joint manipulation performed with wrist block anesthesia.
The average NRS for pain during infiltration was 4.7. Pain was present before manipulation in 52.6% of patients. Pain from manipulation showed an average NRS score of 3.6. The amounts of pain at CCH infiltration, pain after 24 hours, and pain from the manipulation were correlated because patients who experienced pain during CCH infiltration were more likely to report experiencing pain during manipulation.
Collagenase Clostridium histolyticum injection for treating Dupuytren contracture can be a painful process. There is a clear relationship between a patient's level of pain during injection of CCH and the likelihood that the patient will experience pain during manipulation, even with the use of local anesthesia.
TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic IV.
本研究的主要目的是量化与溶组织梭状芽孢杆菌胶原酶(CCH)注射相关的疼痛程度,并确定其是否与干预中的其他因素有关。
对135例患者进行前瞻性研究,以评估治疗期间3个时间点的疼痛情况:(1)CCH注射后,使用数字评分量表(NRS);(2)CCH注射24小时后且拆除绷带后,在手法操作前进行二元(阳性/阴性)评估;(3)在腕部阻滞麻醉下进行关节手法操作后。
浸润期间疼痛的平均NRS为4.7。52.6%的患者在手法操作前存在疼痛。手法操作引起的疼痛平均NRS评分为3.6。CCH浸润时的疼痛、24小时后的疼痛和手法操作引起的疼痛程度相关,因为在CCH浸润期间经历疼痛的患者在手法操作时更有可能报告疼痛。
注射溶组织梭状芽孢杆菌胶原酶治疗掌腱膜挛缩可能是一个痛苦的过程。即使使用局部麻醉,患者在注射CCH时的疼痛程度与患者在手法操作时经历疼痛的可能性之间也存在明显的关系。
研究类型/证据水平:预后性研究IV级。